Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren’s syndrome

Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren’s syndrome

(2015) Elena Pontarini et al.   RHEUMATOLOGY

A BAFF Receptor His159Tyr Mutation in Sjögren's Syndrome-Related Lymphoproliferation

(2015) Aristea Papageorgiou et al.   Arthritis & Rheumatology

Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival

(2014) Ayan Lahiri et al.   JOURNAL OF AUTOIMMUNITY

B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren’s syndrome: the similarities and differences

(2014) Wei Lin et al.   ARTHRITIS RESEARCH & THERAPY

Primary Sjögren's Syndrome Is Characterized by Distinct Phenotypic and Transcriptional Profiles of IgD+ Unswitched Memory B Cells

(2014) Mustimbo E. P. Roberts et al.   Arthritis & Rheumatology

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

(2013) Xavier Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity

(2013) Fabien B. Vincent et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Feeling a Little SYK after Mixing BAFF with BCR

(2013) Simona Infantino et al.   IMMUNITY

B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome

(2013) Adrianos Nezos et al.   JOURNAL OF AUTOIMMUNITY

Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation

(2013) Radhika Goenka et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Advances in understanding the pathogenesis of primary Sjögren's syndrome

(2013) Gaëtane Nocturne et al.   Nature Reviews Rheumatology

Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and Effects

(2013) He Li et al.   Frontiers in Immunology

BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands

(2012) L. Quartuccio et al.   RHEUMATOLOGY

n−3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell activating factor (BAFF) transgenic mice

(2011) Rosalia Crupi et al.   PREVENTIVE MEDICINE

Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome

(2011) Keiko Yoshimoto et al.   ARTHRITIS RESEARCH & THERAPY

Disturbance of cytokine networks in Sjögren's syndrome

(2011) Pierre Youinou et al.   ARTHRITIS RESEARCH & THERAPY

Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome

(2010) Michael Voulgarelis et al.   Nature Reviews Rheumatology

B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren’s Syndrome

(2010) F. Lavie et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells

(2009) Sung-Tak Jeon et al.   IMMUNOLOGY AND CELL BIOLOGY

Is the blood B-cell subset profile diagnostic for Sjogren syndrome?

(2008) A Binard et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells

(2008) Katsuya Suzuki et al.   CYTOKINE

Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome

(2008) Youcun Qian et al.   EUROPEAN JOURNAL OF IMMUNOLOGY